ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Real-world observations and impacts of Chinese herbal medicine for migraine: results of a registry-based cohort study

Lyu, Shaohua; Zhang, Claire Shuiqing; Zhang, Anthony Lin; Guo, Xinfeng; Hua, Rong; Mao, Zhenhui; Su, Qiaozhen; Xue, Charlie Changli*; Sun, Jingbo*广东省人民医院; 广州中医药大学
Frontiers in Pharmacology2024-2-2DOI: 10.3389/fphar.2024.1330589
16阅读
引用收藏
分享

摘要

Background: Migraine is a prevalent, recurrent condition with substantial disease burden. Chinese herbal medicine (CHM) has been used frequently for migraine in controlled clinical settings. This study is to summarise the characteristics of patients who seek clinical care in a tertiary Chinese medicine hospital in China; to gather their preferences and values of using CHM; to explore the effect of CHM for migraine and its comorbidities in a real-world setting, and to collect first-hand expertise of clinicians' practice pattern in prescribing CHM for migraine.Methods: This registry-based cohort study was prospectively conducted at Guangdong Provincial Hospital of Chinese Medicine from December 2020 to May 2022. Adult migraine patients seeking their initial anti-migraine clinical care at the hospital were consecutively recruited and followed up for 12 weeks. Practitioners specialised in headache management prescribed individualised treatments without research interference. Standardised case report forms were employed to gather information on patients' preferences and perspective of seeking clinical care, as well as to assess participants' migraine severity, comorbidities, and quality of life, at 4-weeks intervals. Various analytical methods were utilised based on the computed data.Results: In this study, we observed 248 participants. Of these, 73 received CHM treatment for 28 days or longer. Notably, these participants exhibited a greater disease severity, compared to those treated with CHM for less than 28 days. Of the 248 participants, 83.47% of them expected CHM would effectively reduce the severity of their migraine, around 50% expected effects for migraine-associated comorbidities, while 51.61% expressing concerns about potential side effects. CHM appeared to be effective in reducing monthly migraine days and pain intensity, improving patients' quality of life, and potentially reducing comorbid anxiety, with a minimum of 28 days CHM treatment. Herbs such as gan cao, gui zhi, chuan xiong, fu ling, bai zhu, yan hu suo, etc. were frequently prescribed for migraine, based on patients' specific symptoms.Conclusion: CHM appeared to be beneficial for migraine and comorbid anxiety in real-world clinical practice when used continuously for 28 days or more.Clinical Trial Registration: clinicaltrials.gov, identifier ChiCTR2000041003.

学科与关键词

关键词
migraineChinese herbal medicinereal-worldcohort studypreferences and valuesclinical expertise
相关
加载中…
  • Migraine patients visiting Chinese medicine hospital: Protocol for a prospective, registry-based, real-world observational cohort study
    Lyu, Shaohua; Zhang, Claire Shuiqing; Zhang, Anthony Lin; Sun, Jingbo; Xue, Charlie Changli*; Guo, Xinfeng*PLoS One, 2022, 17(3): e0265137.被引 2
  • Chinese herbal medicine for migraine management: A hospital-based retrospective analysis of electronic medical records
    Lyu, Shaohua; Zhang, Claire Shuiqing; Sun, Jingbo; Weng, Heng; Xue, Charlie Changli; Guo, Xinfeng*; Zhang, Anthony Lin*Frontiers in Medicine, 2022, 9: 936234.被引 1
  • Efficacy and Safety of Oral Chinese Herbal Medicine for Migraine: A Systematic Review and Meta-Analyses Using Robust Variance Estimation Model
    Lyu, Shaohua; Zhang, Claire Shuiqing; Guo, Xinfeng; Zhang, Anthony Lin; Sun, Jingbo; Chen, Genghang; Xue, Charlie Changli*; Luo, Xiaodong*Frontiers in Neurology, 2022, 13: 889336.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2024-02-02
卷期
第 15 卷
页码
1330589
DOI
10.3389/fphar.2024.1330589
语言
ENGLISH
成果收录
SCIE
资助标注
National Key Research and Development Program of China10.13039/501100012166

作者

  • L

    Lyu, Shaohua (第一作者)

    2 · guangdong prov hosp · guangzhou univ chinese med

  • Z

    Zhang, Claire Shuiqing

查看全部 9 位作者收起作者
  • Z

    Zhang, Anthony Lin

  • G

    Guo, Xinfeng

    2 · guangdong prov hosp · guangzhou univ chinese med

  • H

    Hua, Rong

    2 · guangdong prov hosp · guangzhou univ chinese med

  • M

    Mao, Zhenhui

    2 · guangdong prov hosp · guangzhou univ chinese med

  • S

    Su, Qiaozhen

    2 · guangdong prov hosp · guangzhou univ chinese med

  • X

    Xue, Charlie Changli (通讯)

    2 · guangdong prov hosp · guangzhou univ chinese med

  • S

    Sun, Jingbo (通讯)

    2 · guangdong prov hosp · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417